TYK2 and COVID-19: Inhibits JAK3, JAK1, JAK2, and to a lesser extent TYK2 and inhibits receptor signaling through pairs of JAK2 and because it can suppress the production of different cytokines, such as IL-2, IL-7 and IL-6 can used for patients with COVID-19.